ARTICLE | Financial News
Quest planning $1.3B note deal
March 22, 2011 1:02 AM UTC
Quest Diagnostics Inc. (NYSE:DGX) plans to sell $1.3 billion in senior unsecured notes. Morgan Stanley; Goldman Sachs; RBS; JPMorgan; and Wells Fargo are book-running managers. Quest said it will use the proceeds to fund its acquisition of the Athena Diagnostics Inc. unit of Thermo Fisher Scientific Inc. (NYSE:TMO), and to repay its outstanding senior unsecured revolving credit facility and secured receivables credit facility. ...